title: Is the use of anti-androgen monotherapy appropriate in patients with advanced prostate cancer?
authors.forename: M
authors.initials: M
authors.lastname: Roach
authors.forename: D
authors.initials: D
authors.lastname: Reese
authors.forename: V
authors.initials: V
authors.lastname: Weinberg
authors.forename: E J
authors.initials: EJ
authors.lastname: Small
authors.forename: P R
authors.initials: PR
authors.lastname: Carroll
mesh_terms: D000726:Androgen Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000813:Anilides / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards; D006801:Humans; D008297:Male; D009367:Neoplasm Staging / Q000592:standards; D009570:Nitriles; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011788:Quality of Life; D015203:Reproducibility of Results; D012107:Research Design / Q000592:standards; D018401:Sample Size; D014105:Tosyl Compounds; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D000813:Anilides; D009570:Nitriles; D014105:Tosyl Compounds; C053541:bicalutamide